Alphamab Oncology has dosed the first subject in the randomised Phase III JSKN003-306 trial of its anti-human epidermal ...

OnCusp Therapeutics receives US FDA fast track designation for CUSP06 for treatment of platinum-resistant ovarian cancer: Princeton, New Jersey Saturday, February 15, 2025, 15:00 ...

New antibody AHA-1031 shows potential in treating non small cell lung cancer resistant to immunotherapy, offering new hope.

SHE had up built a business empire by claiming she was curing her brain tumour with ‘nutrition, patience, determination and love’. But Belle Gibson’s millions of followers and mega bucks business ...

Strong early U.S. YORVIPATH® launch with 908 prescriptions as of Feb. 7, 2025; YORVIPATH full year 2024 revenue of €28.7 million - Following pre-NDA meeting with FDA, on track to submit TransCon CNP ...

With the start of a new semester, I’ve been utilizing my free time — primarily on weekends — to work through my watchlist.

Patients with metastatic cancer had better quality of life, clinical outcomes, and sense of well-being when they regularly ...

An enzyme called cyclin-dependent kinase 2 (CDK2) regulates the cell cycle and may have the potential to drive therapeutic ...

NBC News’ Kate Snow talks with hairdresser Hector Corvera who was diagnosed with bladder cancer in 2023. He is the plaintiff ...

New York Gov. Kathy Hochul (D) weighed in on the recent extradition order in place for a New York doctor who allegedly sent ...

Scientists from Rice University and their collaborators have unveiled a groundbreaking technique to combat cancer cells, ...

HER2, a HER2-targeted immunotherapy, with plans for FDA submission following promising Phase 2b data in osteosarcoma.